Comparison of the effect of various antisera and cobra venom factor on inflammatory reactions in guinea-pig skin. I. Non-specific inflammation due to the intradermal injection of turpentine.
Guinea-pigs were treated with agents which lowered the serum complement levels and the effect on the inflammatory reaction to intradermal turpentine was studied. A comparison was made between two antisera to beta1C/beta1A globulin which had been prepared in different ways. One was made using C3 fixed to zymosan particles as the antigen, and the other using chemically extracted beta 1C/beta1A globulin. The antisera to beta1C/beta1A globulin (zymosan) was found to have the greater anti-inflammatory activity. The effect of each on the parameters of complement studied, and on the circulating platelet count, was much the same. An antiserum to serum factors fixed to zymosan during C3 activication was prepared free of anti-beta1C/beta1A globulin antibodies. This was found to have some of the anti-inflammatory activity of the anti-beta1C/beta1A globulin (zymosan), as well as lowering total complement levels. Anti-gamma globulin andheterologous immune complexes also lowered serum complement levels and were antiinflammatory. However, all the above agents were also found to reduce the number of circulating platelets. This was in contrast to CVF which reduced complement levels by 90 per cent. but had no effect on platelet numbers. CVF also reduced the inflammatory response but was no more effective than the other agents. In view of these findings a role for the participation of the complement system, possibly involving the alternate pathway of activation of C3, is discussed as well as the participation of platelets in the reaction.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000936:Antigen-Antibody Complex; D001772:Blood Cell Count; D001792:Blood Platelets / Q000276:immunology; D003176:Complement C3 / Q000032:analysis; D005916:Globulins / Q000032:analysis; D006168:Guinea Pigs; D007104:Immune Adherence Reaction; D007106:Immune Sera; D007249:Inflammation; D007271:Injections, Intradermal; D008297:Male; D011817:Rabbits / Q000276:immunology; D012867:Skin / Q000276:immunology; D012910:Snake Venoms; D014425:Turpentine / Q000276:immunology; D014688:Venoms; D015054:Zymosan / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D000936:Antigen-Antibody Complex; D003176:Complement C3; D005916:Globulins; D007106:Immune Sera; D012910:Snake Venoms; D014688:Venoms; D015054:Zymosan; D014425:Turpentine